Volume 89 Issue 33 | pp. 21-23
Issue Date: August 15, 2011

Pipeline Payoff Helps Pharma

Drug company first-half results were helped by new product launches and emerging-market sales
Department: Business | Collection: Economy
Keywords: pharmaceuticals, biotechnology, earnings, sales

If the first quarter of 2011 was all about promises of things to come, the second quarter saw some actual results. Many of the major pharmaceutical companies focused their recent earnings reports on new products and new markets for them. At the same time, they continued to make cuts in light of generics competition.

Novartis was among those bearing the most fruit. The Swiss company reported four new product approvals in the quarter, giving . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society